Mary Rinella, MD
- Achieved national recognition for her basic science and clinical research on the pathophysiology and management of non-alcoholic steatohepatitis (NASH)
- Recipient of the American Gastroenterological Association (AGA) Research Scholar Award and a 5 year NIH career development award (K08)
- Chair, GI Fellowship Education Committee
- Fluent in French and Spanish
What publications are you working on currently?
This week I submitted a randomized controlled trial of pentoxifylline for the treatment of NASH. I found that the drug was well tolerated and improved liver enzymes and liver histology. I’m also completing a manuscript on the mechanisms of cell injury in a mouse model of NAFLD.
What are your research and clinical interests?
My main area of focus is fatty liver both from a basic science perspective as well as clinical. It’s the most common liver disease and will surpass HCV as an indication for liver transplant within the next decade or so. I am very involved in basic and clinical research and have a strong interest in education. I have a busy clinical practice with a focus on Non-alcoholic fatty liver disease (NAFLD). To stay on top of current trends and discoveries, I regularly read Hepatology, Gastroenterology, Journal of Hepatology, NEJM.
How do you fit in as a member of the Northwestern team?
I have a very strong commitment to resident and fellow education. I chair the Fellowship Education Committee and I am on the Fellowship Selection Committee. I plan to continue working at Northwestern because I love the great camaraderie and the intense learning environment.
What advice do you have for prospective NU Residents?
Work hard, take any opportunity you have to learn and read as much as you can. Just don’t forget to get out of the hospital and enjoy yourself – it makes life better and work more meaningful.